532激光治疗中心性浆液性脉络膜视网膜病变的疗效观察

532 laser photocoagulation for the treatment of central serous chorioretinopathy

目的:观察532激光治疗中心性浆液性脉络膜视网膜病变的疗效。方法:对我科近3a来门诊及住院的40例中心性浆液性脉络膜视网膜病变患者分为两组,治疗组20例20眼,对照组20例21眼。治疗组应用532激光治疗,口服复方芦丁、卵磷脂络合碘。对照组给予口服复方芦丁、卵磷脂络合碘。结果:治疗组激光治疗1mo后有6眼治愈,2mo后共有16眼治愈,3mo后共有20眼治愈;对照组1mo后有1眼治愈,2mo后共有4眼治愈,3mo后共有17眼治愈,6mo后共有21眼治愈。两组相比,在1mo和2mo后差异有非常显著性(P<0.01),在3mo后差异无显著性(P>0.05)。结论:中心性浆液性脉络膜视网膜病变进行532激光治疗是安全有效的。

AIM ： To observe the effect of 532 laser photocoagulation for the treatment of central serous chorioretinopathy.METHODS： For the past three years, 40 cases with central serous chorioretinopathy in our department were divided into two groups, the treatment group（20 patients, 20 eyes） and the control group （20 cases, 21 eyes）. Patients in the treatment group were treated by 532 laser photocoagulation and taken compound rutin and Iodized Lecithin orally. The control group only taken compound rutin and Iodized Lecithin orally. RESULTS： For the treatment group, 6 eyes, 16 eyes and 20 eyes were cured one month, two months and three months after laser therapy respectively. For the control group, 1,4,17 and 21 eyes were cured one month, two, three and six months after treatment respectively. The difference between the two groups one month and two months latter was highly significant （ P 〈 0.01）, but was not significant 3 months latter（ P〉 0.05）. CONCLUSION： 532 laser photocoagulation for the treatment of central serous chorioretinopathy seems to be safe and effective.